Jennifer L. Good, President & CEO: Trevi Therapeutics TRVI Sell · Filed 25/03/25

Trade details

Type: Insider sale
Amount: $34,630.54
Shares · price: 5,263 sh · $6.58 a share
Held after: 213,313 sh
Stock: Trevi Therapeutics TRVI
Person: Jennifer L. GoodPresident & CEO
Trade date: 25/03/21
Filed: 25/03/25
Days to filing: 4 days

Sold 2.4% of holdings

Share of holding sold: 2.4%

Trevi Therapeutics trades, last 26 weeks

What else happened in Trevi Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/19~25/04/20

Jennifer L. Good's recent trades

Jennifer L. GoodOfficer
Planned saleTrevi Therapeutics
Planned sale
Trevi Therapeutics
TRVI
$34.6K
5,263 sh
$34.6K
Filed 25/03/21
Traded 25/03/21
Jennifer L. GoodDirector
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$1.7M
31,751 sh
$1.7M
Filed 24/09/19
Traded 24/09/17
Jennifer L. GoodDirector
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$1.9M
37,241 sh
$1.9M
Filed 24/09/11
Traded 24/09/09
Jennifer L. GoodPresident & CEO
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$12.8K
4,219 sh
$12.8K
Filed 24/09/09
Traded 24/09/06
Jennifer L. GoodPresident & CEO
SellTrevi Therapeutics
Sell
Trevi Therapeutics
TRVI
$5,594
1,840 sh
$5,594
Filed 24/09/09
Traded 24/09/09